News from boston scientific corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

09:00 ET

Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge™ Surgical Leads For The Precision Spectra™ Spinal Cord Stimulator (SCS) System

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) and CE Mark approval for the CoverEdge™ 32 and...

Oct 20, 2014, 08:00 ET

Boston Scientific Initiates Study Of Promus PREMIER™ Coronary Stent System In Underserved Patient Populations

 As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation (NYSE: BSX) has initiated the PLATINUM...

Oct 16, 2014, 16:30 ET

Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADETM pacemaker family. When implanted with the company's...

Oct 08, 2014, 19:59 ET

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

 After reviewing updated data and analysis for the Boston Scientific Corporation (NYSE: BSX) WATCHMAN™ Left Atrial Appendage Closure...

Oct 01, 2014, 08:30 ET

Boston Scientific To Webcast Conference Call Discussing Third Quarter 2014 Financial Results On October 22

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third...

Sep 23, 2014, 16:05 ET

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of...

Sep 17, 2014, 00:00 ET

Boston Scientific Receives CE Mark For The Vercise™ Deep Brain Stimulation (DBS) System For Treating Patients With Tremor

 Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Vercise™ Deep Brain Stimulation (DBS) System for the treatment of...

Sep 10, 2014, 09:00 ET

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Beginning Saturday, Boston Scientific Corporation (NYSE: BSX) will present data that reinforce the company's commitment to advancing science for...

Sep 03, 2014, 08:00 ET

Boston Scientific To Participate In 2014 Bank Of America Merrill Lynch Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Bank of America Merrill Lynch Global Healthcare Conference on...

Sep 02, 2014, 08:00 ET

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

 Boston Scientific Corporation (NYSE: BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer AG....

Aug 30, 2014, 12:38 ET

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

 Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial, the...

Aug 29, 2014, 17:00 ET

Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents

 A Boston Scientific Corporation (NYSE: BSX) prospective, multinational study on stent removability and preliminary long term stricture...

Aug 25, 2014, 15:45 ET

Boston Scientific To Participate In 2014 Morgan Stanley Global Healthcare Conference

 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2014 Morgan Stanley Global Healthcare Conference on September 8...

Aug 19, 2014, 02:30 ET

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized...

Jul 24, 2014, 07:00 ET

Boston Scientific Announces Results For Second Quarter Ended June 30, 2014

Boston Scientific Corporation (NYSE: BSX) generated sales of $1.873 billion during the second quarter ended June 30, 2014, compared to the...

Jul 23, 2014, 17:00 ET

Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon

 Continuing to advance the development of innovative treatment options for coronary artery disease, Boston Scientific Corporation (NYSE: BSX)...

Jul 22, 2014, 09:00 ET

Boston Scientific Launches POLARIS™ Imaging System

 Boston Scientific Corporation (NYSE: BSX) has initiated full commercial launch of the new POLARIS™ Imaging System.  This system...

Jul 21, 2014, 16:30 ET

Boston Scientific Receives FDA Approval for REBEL™ Platinum Chromium Coronary Stent System

 Boston Scientific Corporation (NYSE: BSX) has received FDA approval for the REBEL™ Platinum Chromium Coronary Stent System, the...

Jul 14, 2014, 19:15 ET

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

 Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European commercial launch of its new 25 mm Lotus™...

Jul 14, 2014, 09:00 ET

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

 Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific...